GPT and metabolic dysfunction-associated steatotic liver disease: Recently, a randomized clinical trial with 111 patients with MASLD, Dellinger et al. [110] observed that supplementation with NR+ pterostilbene significantly decreased ALT and Gamma-glutamyl Transferase levels; however, no significant differences were observed in the primary endpoint, which was the reduction in liver fat.